Related Experiment Video

Updated: Dec 11, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

757

Cardiometabolic medicine - the US perspective on a new subspecialty

Cara Reiter-Brennan1,2, Miguel Cainzos-Achirica1, Garshasb Soroosh1

  • 1Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Cardiovascular Endocrinology & Metabolism
|August 18, 2020
PubMed

Insights

A new medical subspecialty, cardiometabolic medicine, is proposed to address the growing burden of cardiovascular disease and diabetes. This involves integrated training in cardiology, endocrinology, and other essential disciplines for comprehensive patient care.

Area of Science:

  • Cardiology and Endocrinology
  • Public Health

Background:

  • Rising prevalence of cardiovascular disease and diabetes worldwide necessitates innovative healthcare solutions.
  • Current healthcare systems face increasing burdens due to complex cardiometabolic conditions.
  • Existing medical training structures may not adequately prepare physicians for managing these multifaceted diseases.

Purpose of the Study:

  • To advocate for the establishment of a new medical subspecialty: cardiometabolic medicine.
  • To propose a comprehensive training program for this emerging field.
  • To emphasize the need for an interdisciplinary approach to cardiometabolic patient care.

Main Methods:

  • Literature review of PubMed articles and analysis of professional society guidelines.
  • Synthesis of knowledge from cardiology, endocrinology, epidemiology, biostatistics, behavioral science, and psychology.
  • Development of a proposed curriculum framework for cardiometabolic medicine specialization.

Main Results:

  • A detailed curriculum integrating core concepts from multiple disciplines is outlined.
  • Cardiometabolic medicine training should span from medical school through continuing medical education (CME).
  • The proposed specialization aims to enhance the care of patients with multiple co-morbidities.

Conclusions:

  • Establishing cardiometabolic medicine as a subspecialty is crucial for managing the global health crisis of cardiometabolic diseases.
  • A paradigm shift towards interdisciplinary and collaborative training and treatment is essential.
  • Lifelong learning in cardiometabolic medicine will improve patient outcomes and reduce healthcare system strain.

Keywords:
cardiologydiabetesendocrinologymetabolismprevention

More Related Videos

Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies06:35

Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies

Published on: April 5, 2024

1.5K
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.8K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
185
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
288
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
242
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.8K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
312
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
354